152 related articles for article (PubMed ID: 23776289)
1. Effects of light-activated diazido-PtIV complexes on cancer cells in vitro.
Bednarski PJ; Korpis K; Westendorf AF; Perfahl S; Grünert R
Philos Trans A Math Phys Eng Sci; 2013 Jul; 371(1995):20120118. PubMed ID: 23776289
[TBL] [Abstract][Full Text] [Related]
2. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
Westendorf AF; Bodtke A; Bednarski PJ
Dalton Trans; 2011 May; 40(19):5342-51. PubMed ID: 21461431
[TBL] [Abstract][Full Text] [Related]
3. Photoactivatable platinum complexes.
Bednarski PJ; Mackay FS; Sadler PJ
Anticancer Agents Med Chem; 2007 Jan; 7(1):75-93. PubMed ID: 17266506
[TBL] [Abstract][Full Text] [Related]
4. Light-activated destruction of cancer cell nuclei by platinum diazide complexes.
Bednarski PJ; Grünert R; Zielzki M; Wellner A; Mackay FS; Sadler PJ
Chem Biol; 2006 Jan; 13(1):61-7. PubMed ID: 16426972
[TBL] [Abstract][Full Text] [Related]
5. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.
Zhao Y; Woods JA; Farrer NJ; Robinson KS; Pracharova J; Kasparkova J; Novakova O; Li H; Salassa L; Pizarro AM; Clarkson GJ; Song L; Brabec V; Sadler PJ
Chemistry; 2013 Jul; 19(29):9578-91. PubMed ID: 23733242
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
[TBL] [Abstract][Full Text] [Related]
7. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
8. A photoactivated trans-diammine platinum complex as cytotoxic as cisplatin.
Mackay FS; Woods JA; Moseley H; Ferguson J; Dawson A; Parsons S; Sadler PJ
Chemistry; 2006 Apr; 12(11):3155-61. PubMed ID: 16470886
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
10. Formation of platinated GG cross-links on DNA by photoactivation of a platinum(IV) azide complex.
Kaspárková J; Mackay FS; Brabec V; Sadler PJ
J Biol Inorg Chem; 2003 Sep; 8(7):741-5. PubMed ID: 14505077
[TBL] [Abstract][Full Text] [Related]
11. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.
Farrell N; Kelland LR; Roberts JD; Van Beusichem M
Cancer Res; 1992 Sep; 52(18):5065-72. PubMed ID: 1516063
[TBL] [Abstract][Full Text] [Related]
12. Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light-activated antitumor platinum complex that kills human cancer cells by an apoptosis-independent mechanism.
Westendorf AF; Woods JA; Korpis K; Farrer NJ; Salassa L; Robinson K; Appleyard V; Murray K; Grünert R; Thompson AM; Sadler PJ; Bednarski PJ
Mol Cancer Ther; 2012 Sep; 11(9):1894-904. PubMed ID: 22710878
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
Kelland LR; Mistry P; Abel G; Loh SY; O'Neill CF; Murrer BA; Harrap KR
Cancer Res; 1992 Jul; 52(14):3857-64. PubMed ID: 1617660
[TBL] [Abstract][Full Text] [Related]
15. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
16. Photolysis of an iodoplatinum(IV) diamine complex to cytotoxic species by visible light.
Kratochwil NA; Bednarski PJ; Mrozek H; Vogler A; Nagle JK
Anticancer Drug Des; 1996 Mar; 11(2):155-71. PubMed ID: 8630187
[TBL] [Abstract][Full Text] [Related]
17. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.
Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ
Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370
[TBL] [Abstract][Full Text] [Related]
19. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
[TBL] [Abstract][Full Text] [Related]
20. Light-induced catalytic and cytotoxic properties of phosphorescent transition metal compounds with a d8 electronic configuration.
To WP; Zou T; Sun RW; Che CM
Philos Trans A Math Phys Eng Sci; 2013 Jul; 371(1995):20120126. PubMed ID: 23776290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
